Companies: 10,795·Total market cap: $144.5T
BioPharma Credit PLC

BioPharma Credit PLC

BOPCFOTCFinancial Services● Active
$0.91
+$0.91(+82064.72%)
Market Cap$1.0B
P/E Ratio
52W High$1.02
52W Low$0.8364
Overview

BioPharma Credit PLC (BOPCF) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · BOPCF · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income$0.13B$0.12B$0.11B$0.18B$0.08B
Depreciation & Amort.$0.00B$0.00B$0.00B$0.00B$0.00B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital($0.02B)($0.01B)($0.01B)$0.01B($0.01B)
Net Cash from Operations$0.09B$0.11B$0.12B$0.18B$0.10B
Investing Activities
Capital Expenditure$0.00B$0.00B$0.00B$0.00B$0.00B
Purchases of Investments($0.08B)$0.00B($0.04B)($0.10B)($0.19B)
Sales of Investments$0.16B$0.04B$0.04B$0.15B$0.09B
Net Cash from Investing$0.08B$0.04B($0.00B)$0.05B($0.09B)
Financing Activities
Common Stock Repurchased($0.05B)($0.11B)($0.02B)($0.05B)$0.00B
Dividends Paid($0.11B)($0.17B)($0.09B)($0.16B)($0.10B)
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Financing($0.16B)($0.28B)($0.11B)($0.21B)($0.10B)
Free Cash Flow
Free Cash Flow$0.09B$0.11B$0.12B$0.18B$0.10B
FCF Margin %(computed)64.96%89.92%90.75%100.02%109.62%

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more BioPharma Credit PLC data

About BioPharma Credit PLC (BOPCF) Cash Flow Statement

BioPharma Credit PLC generated operating cash flow of $0.09B and free cash flow of $0.09B for 2025 — a FCF margin of 64.96%. Capital expenditure was $0.00B.

Frequently asked questions

BOPCF · 4 questions

BioPharma Credit PLC generated free cash flow of $0.09B for 2025, down 18.6% year-over-year.

BOPCF free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10